Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, USA.
Int J Health Policy Manag. 2019 Jan 1;8(1):49-50. doi: 10.15171/ijhpm.2018.94.
In a rigorous systematic review, Dukhanin and colleagues categorize metrics and evaluative tools of the engagement of patient, public, consumer, and community in decision-making in healthcare institutions and systems. The review itself is ably done and the categorizations lead to a useful understanding of the necessary elements of engagement, and a suite of measures relevant to implementing engagement in systems. Nevertheless, the question remains whether the engagement of patient representatives in institutional or systemic deliberations will lead to improved clinical outcomes or increased engagement of individual patients themselves in care. Attention to the conceptual foundations of patient engagement would help make this systematic review relevant to the clinical care of patients.
在一项严格的系统评价中,Dukhanin 及其同事对医疗机构和系统中患者、公众、消费者和社区参与决策的衡量标准和评估工具进行了分类。该综述本身做得很好,分类有助于人们理解参与的必要要素,以及一套与系统实施参与相关的措施。然而,问题仍然是,患者代表在机构或系统审议中的参与是否会导致临床结果的改善,或者是否会增加患者自身对护理的参与。关注患者参与的概念基础将有助于使这项系统评价与患者的临床护理相关。